Lin Wang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Chronic Kidney Disease

Ejection Fraction

Top Venues

EMBO molecular medicine

Molecules (Basel, Switzerland)

Biomedical chromatography : BMC

This page only lists publications with an associated author ORCID identifier.

Publications

Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Man Su, Xianru Liu, Yuru Zhao, Yatong Zhu, Mengqiu Wu, Kun Liu, Gangqiang Yang, Wanhui Liu, Lin Wang
In Silico and In Vivo Pharmacokinetic Evaluation of 84-B10, a Novel Drug Candidate against Acute Kidney Injury and Chronic Kidney Disease. Molecules (Basel, Switzerland) 29 (1) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Man Su, Xianru Liu, Yuru Zhao, Yatong Zhu, Mengqiu Wu, Kun Liu, Gangqiang Yang, Wanhui Liu, Lin Wang
In Silico and In Vivo Pharmacokinetic Evaluation of 84-B10, a Novel Drug Candidate against Acute Kidney Injury and Chronic Kidney Disease. Molecules (Basel, Switzerland) 29 (1) (2023)
Mi Bai, Mengqiu Wu, Mingzhu Jiang, Jia He, Xu Deng, Shuang Xu, Jiaojiao Fan, Mengqiu Miao, Ting Wang, Yuting Li, Xiaowen Yu, Lin Wang, Yue Zhang, Songming Huang, Li Yang, Zhanjun Jia, Aihua Zhang
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease. EMBO molecular medicine 15 (2) (2023)
Lin Wang, Xiangping Li, Ying Kong, Qiuyan Zhang, Honglei Xie
Development of a sensitive UHPLC-MS/MS method for the pharmacokinetics study of a novel tyrosine kinase inhibitors, 1-[4-(4-{5-Chloro-4-[2-(propane-2-sulfonyl)-phenylamino]-pyrimidin-2-ylamino}-phenyl)-piperazin-1-yl]-propenone in rats. Biomedical chromatography : BMC 35 (5) (2021)
Shuangshuang Sun, Dongfang Cheng, Shumeng Kong, Xiangping Li, Tongfang Li, Qinglong Yu, Lin Wang
A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline. Biomedical chromatography : BMC 34 (1) (2019)